Search research articles
Contact Us
Filters
Showing results (31-40 of 40) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 40 results.
European Journal of Preventive Cardiology
|
June 2, 2023
Improving 10-year cardiovascular risk prediction in apparently healthy people: flexible addition of risk modifiers on top of SCORE2
Steven H J Hageman, Carmen Petitjaen, Lisa Pennells, et al.
European Journal of Preventive Cardiology
|
February 9, 2026
Improving 10-year cardiovascular risk prediction in patients with established cardiovascular disease: flexible addition of risk predictors on top of the SMART2 risk score
Joris Holtrop, Mari N Gynnild, Matthew Richards, et al.
European Heart Journal
|
February 15, 2022
Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithm
Steven H J Hageman, Ailsa J McKay, Peter Ueda, et al.
European Journal of Preventive Cardiology
|
May 19, 2021
Residual cardiovascular risk reduction guided by lifetime benefit estimation in patients with symptomatic atherosclerotic disease: effectiveness and cost-effectiveness
Steven H J Hageman, Jannick A N Dorresteijn, Michiel L Bots, et al.
European Heart Journal
|
March 11, 2026
Risk prediction in patients with heart failure with preserved ejection fraction: the LIFE-Preserved model
Tessa H Reitsma, Gianluigi Savarese, Łukasz Kuźma, et al.
European Heart Journal
|
March 11, 2026
Prediction of incident heart failure in established atherosclerotic cardiovascular disease: the SMART2-HF model
Tessa H Reitsma, Carl-Emil Lim, Mari N Gynnild, et al.
BMJ Open
|
February 22, 2023
Cohort profile: the Utrecht Cardiovascular Cohort-Second Manifestations of Arterial Disease (UCC-SMART) Study-an ongoing prospective cohort study of patients at high cardiovascular risk in the Netherlands
Maria C Castelijns, Marga A G Helmink, Steven H J Hageman, et al.
European Heart Journal
|
June 5, 2026
Predicting lifetime cardiovascular risk and benefits of preventive treatment in patients with established atherosclerotic cardiovascular disease: the SMART-REACH2 model
Joris Holtrop, Mari N Gynnild, Salil V Deo, et al.
European Journal of Preventive Cardiology
|
August 16, 2022
Including measures of chronic kidney disease to improve cardiovascular risk prediction by SCORE2 and SCORE2-OP
Kunihiro Matsushita, Stephen Kaptoge, Steven H J Hageman, et al.
European Journal of Preventive Cardiology
|
May 16, 2024
Prediction of individual lifetime cardiovascular risk and potential treatment benefit: development and recalibration of the LIFE-CVD2 model to four European risk regions
Steven H J Hageman, Stephen Kaptoge, Tamar I de Vries, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 40) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 40 results.
European Journal of Preventive Cardiology
|
June 2, 2023
Improving 10-year cardiovascular risk prediction in apparently healthy people: flexible addition of risk modifiers on top of SCORE2
Steven H J Hageman, Carmen Petitjaen, Lisa Pennells, et al.
European Journal of Preventive Cardiology
|
February 9, 2026
Improving 10-year cardiovascular risk prediction in patients with established cardiovascular disease: flexible addition of risk predictors on top of the SMART2 risk score
Joris Holtrop, Mari N Gynnild, Matthew Richards, et al.
European Heart Journal
|
February 15, 2022
Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithm
Steven H J Hageman, Ailsa J McKay, Peter Ueda, et al.
European Journal of Preventive Cardiology
|
May 19, 2021
Residual cardiovascular risk reduction guided by lifetime benefit estimation in patients with symptomatic atherosclerotic disease: effectiveness and cost-effectiveness
Steven H J Hageman, Jannick A N Dorresteijn, Michiel L Bots, et al.
European Heart Journal
|
March 11, 2026
Risk prediction in patients with heart failure with preserved ejection fraction: the LIFE-Preserved model
Tessa H Reitsma, Gianluigi Savarese, Łukasz Kuźma, et al.
European Heart Journal
|
March 11, 2026
Prediction of incident heart failure in established atherosclerotic cardiovascular disease: the SMART2-HF model
Tessa H Reitsma, Carl-Emil Lim, Mari N Gynnild, et al.
BMJ Open
|
February 22, 2023
Cohort profile: the Utrecht Cardiovascular Cohort-Second Manifestations of Arterial Disease (UCC-SMART) Study-an ongoing prospective cohort study of patients at high cardiovascular risk in the Netherlands
Maria C Castelijns, Marga A G Helmink, Steven H J Hageman, et al.
European Heart Journal
|
June 5, 2026
Predicting lifetime cardiovascular risk and benefits of preventive treatment in patients with established atherosclerotic cardiovascular disease: the SMART-REACH2 model
Joris Holtrop, Mari N Gynnild, Salil V Deo, et al.
European Journal of Preventive Cardiology
|
August 16, 2022
Including measures of chronic kidney disease to improve cardiovascular risk prediction by SCORE2 and SCORE2-OP
Kunihiro Matsushita, Stephen Kaptoge, Steven H J Hageman, et al.
European Journal of Preventive Cardiology
|
May 16, 2024
Prediction of individual lifetime cardiovascular risk and potential treatment benefit: development and recalibration of the LIFE-CVD2 model to four European risk regions
Steven H J Hageman, Stephen Kaptoge, Tamar I de Vries, et al.
Page
of 4